can rest easy. It doesn't appear that volume is an issue anymore.
Anytime you have a stock with 75% insider and institutional ownership the possibility for gains is high. I think the stock is finally trying to correct itself to be valued with the rest of biotechnology.
In Singh's presentation he guided for an uplisting in the first quarter. With it already being February it seems that the announcement could come in the immediate future. I think LBIO soars 50% in the week that follows.